Alpha Emitter Market
Alpha Emitter Market - Global Industry Assessment & Forecast
#
Pages:
196
Base Year:
2023
Feb - 2024
Format:
Report Code:
VMR-2419
Segments Covered
By
Radionuclide Radium (Ra-223), Actinium (Ac-225), Lead (Pb-212), Astatine-211, Bismuth-213, Others
-
By
Application Prostate Cancer, Bone Metastases, Ovarian Cancer, Pancreatic Cancer, Endocrine Tumors, Others
-
By
Sources Natural Sources, Artificially produced sources
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 671.2 Million |
 Revenue 2032:
|
USD 1751.5 Million |
 Revenue CAGR
(2024 - 2032): |
11.25% |
Fastest Growing Region (2024 -
2032)
|
Europe |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Alpha Emitter Market Segment Analysis
- Alpha Emitter Radionuclide Outlook (Revenue, USD Million, 2018 - 2030)
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Alpha Emitter Application Outlook (Revenue, USD Million, 2018 - 2030)
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Alpha Emitter Sources Outlook (Revenue, USD Million, 2018 - 2030)
- Natural Sources
- Artificially produced sources
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
-
North America Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
-
North America Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- U.S.
- U.S. Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- U.S. Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- U.S. Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- U.S. Alpha Emitter Market, by Radionuclide
- Canada
- Canada Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Canada Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Canada Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Canada Alpha Emitter Market, by Radionuclide
-
Mexico
- Mexico Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Mexico Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Mexico Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Mexico Alpha Emitter Market, by Radionuclide
-
North America Alpha Emitter Market, by Radionuclide
- Europe
-
Europe Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
-
Europe Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
-
Europe Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- U. K.
- U.K. Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- U.K. Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- U.K. Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- U.K. Alpha Emitter Market, by Radionuclide
- France
- France Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- France Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- France Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- France Alpha Emitter Market, by Radionuclide
-
Germany
- Germany Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Germany Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Germany Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Germany Alpha Emitter Market, by Radionuclide
-
Italy
- Italy Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Italy Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Italy Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Italy Alpha Emitter Market, by Radionuclide
-
Spain
- Spain Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Spain Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Spain Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Spain Alpha Emitter Market, by Radionuclide
-
Rest of Europe
- Rest of Europe Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Rest of Europe Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Rest of Europe Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Rest of Europe Alpha Emitter Market, by Radionuclide
-
Europe Alpha Emitter Market, by Radionuclide
- Asia Pacific
-
Asia Pacific Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
-
Asia Pacific Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
-
Asia Pacific Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- China
- China Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- China Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- China Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- China Alpha Emitter Market, by Radionuclide
- Japan
- Japan Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Japan Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Japan Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Japan Alpha Emitter Market, by Radionuclide
-
Germany
- Germany Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Germany Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Germany Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Germany Alpha Emitter Market, by Radionuclide
-
India
- India Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- India Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- India Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- India Alpha Emitter Market, by Radionuclide
-
South Korea
- South Korea Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- South Korea Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- South Korea Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- South Korea Alpha Emitter Market, by Radionuclide
-
South East Asia
- South East Asia Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- South East Asia Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- South East Asia Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- South East Asia Alpha Emitter Market, by Radionuclide
-
Rest of Asia Pacific
- Rest of Asia Pacific Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Rest of Asia Pacific Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Rest of Asia Pacific Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Rest of Asia Pacific Alpha Emitter Market, by Radionuclide
-
Asia Pacific Alpha Emitter Market, by Radionuclide
- Latin America
-
Latin America Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
-
Latin America Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
-
Latin America Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Brazil
- Brazil Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Brazil Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Brazil Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Brazil Alpha Emitter Market, by Radionuclide
- Argentina
- Argentina Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Argentina Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Argentina Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Argentina Alpha Emitter Market, by Radionuclide
-
Rest of Latin America
- Rest of Latin America Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Rest of Latin America Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Rest of Latin America Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Rest of Latin America Alpha Emitter Market, by Radionuclide
-
Latin America Alpha Emitter Market, by Radionuclide
- Middle East & Africa
-
Middle East & Africa Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
-
Middle East & Africa Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
-
Middle East & Africa Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- GCC Countries
- GCC Countries Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- GCC Countries Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- GCC Countries Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- GCC Countries Alpha Emitter Market, by Radionuclide
- South Africa
- South Africa Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- South Africa Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- South Africa Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- South Africa Alpha Emitter Market, by Radionuclide
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Alpha Emitter Market, by Radionuclide
- Radium (Ra-223)
- Actinium (Ac-225)
- Lead (Pb-212)
- Astatine-211
- Bismuth-213
- Others
- Rest of Middle East & Africa Alpha Emitter Market, by Application
- Prostate Cancer
- Bone Metastases
- Ovarian Cancer
- Pancreatic Cancer
- Endocrine Tumors
- Others
- Rest of Middle East & Africa Alpha Emitter Market, by Sources
- Natural Sources
- Artificially produced sources
- Rest of Middle East & Africa Alpha Emitter Market, by Radionuclide
-
Middle East & Africa Alpha Emitter Market, by Radionuclide
- North America
FAQ
Frequently Asked Question
What is the global demand for Alpha Emitter in terms of revenue?
-
The global Alpha Emitter valued at USD 671.2 Million in 2023 and is expected to reach USD 1751.5 Million in 2032 growing at a CAGR of 11.25%.
Which are the prominent players in the market?
-
The prominent players in the market are Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited., TerraPower, LLC, NIOWAVE Inc. and IONETIX Corporation..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.25% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Alpha Emitter include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Alpha Emitter in 2023.
